We bring you the news you might have missed from the week just gone. The top lines: Health officials in the US have recommended that cannabis be rescheduled to a ‘lower risk’ drug, while the UK Home Affairs Committee called for wider access to cannabis on [...]
Via Business of Cannabis As Switzerland sees the launch of its second cannabis pilot, Cannavigia co-founder Philipp Hagenbach, shares his insights on the country’s approach to reform. Recent weeks have seen the launch of ZüriCan, Switzerland’s second cannabis pilot set to give over 2,000 Zurich inhabitants [...]
Copyright © 2020 – 2026 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.